CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. · 2006

Read CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. by Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2000477.txt.

Description

Dietrich and co-authors showed in 2006 that common chemotherapy drugs can harm brain precursor cells. Cancer patients often report memory problems and white matter damage after treatment. The cell basis for those effects was poorly understood. The team tested carmustine, cisplatin and cytarabine at doses used in patients. They compared brain cells with several cancer cell lines.

All three drugs killed central nervous system progenitor cells more readily than cancer cells. Non-dividing oligodendrocytes, cells that coat nerve fibres, were also highly sensitive. In mice, systemic treatment raised cell death and cut cell division in three brain regions. Some effects lasted for weeks after dosing ended. Lab tests predicted the animal results closely, offering a fast screen for safer therapies.

Catalog record

CREATORDietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M.
YEAR2006
COLLECTIONPAPERS
FORMATTXT
FILE SIZE88 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2000477

Browse the full library · About the Tower of Babel